About Index Trending news
Analyze
Pricing
Antibe Therapeutics

Antibe Therapeutics

Antibe Therapeutics

We are radically improving the safety & effectiveness of NSAIDs, the most widely used drugs for pain & inflammation.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$2,400,000
Post-IPO equity
$786,000
Employees

Team size

10+
Locations
HQ
Headquarters
$2,400,000 Post-IPO equity
businesswire

Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement | Business Wire